Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Rocket Companies Is Under Pressure From Interest Rate Hike Concerns

By Chris Lau, InvestorPlace Contributor

RKT stock broke down below a long-term $20-$21 trading range that lasted after its IPO, after posting a sequential slowdown.

7 Best Battery Stocks to Buy as New Energy Demands Intensify  

By Chris Lau, InvestorPlace Contributor

Government infrastructure spending is lifting new energy demands, with batteries for EVs, solar energy, and the grid getting a strong lift.

Why FuboTV Is Still on Sale After Posting Strong Subscription Growth

By Chris Lau, InvestorPlace Contributor

fuboTV is still on a downtrend that began after the Nasdaq index broke down in February. FUBO stock is unable to shake off the bearishness.

Dogecoin Is a Joke Currency, but the Farce May Continue Indefinitely

By Chris Lau, InvestorPlace Contributor

Elon Musk’s tweets will move DOGE prices, and until it decouples from him, speculators need to other cryptocurrencies.

What is PLTR Stock Worth As Shares Fade Badly?

By Chris Lau, InvestorPlace Contributor

Palantir investors have a wall of worry to climb, hurt by insider selling and paltry revenue in the short-term period.

Load More